Drugs Acting on Dermal Connective Tissue

  • B. Nusgens
  • C. M. Lapière
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 87 / 2)

Abstract

The dermis is a complex tissue composed of differentiated fibroblasts embedded in an extracellular matrix containing various macromolecules: collagens, proteoglycans, elastin and glycoproteins. Interactions between these various constituents and with the cells determine the architectural organisation and the function of the supporting network. The different steps and their potential controls operating in the synthesis, degradation and organisation of these molecules are described in Chap. 9. Each of these steps can potentially be modified or modulated by exogenous agents. The discovery of pharmacological agents active in some of them and the knowledge of their mode of action has helped to elucidate physiological mechanisms. Much of the information about the pharmacology of the dermis is related to fibroblasts and mainly one of their biosynthetic products, collagen. This protein will be considered as a model compound to monitor the activity of drugs on the tissue. Some information will also be briefly presented about elastin, proteoglycans and glycoproteins in the dermis and in tissues other than skin.

Keywords

Corticosteroid Proline Histamine Prostaglandin Pyrene 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alarcon-Segovia D, Ibanez G, Kershenobich D, Rojkind M (1974) Treatment of scleroderma by modification of collagen metabolism. A double blind trial with colchicine-placebo. J Rheumatol 1:97–102Google Scholar
  2. Aycock RS, Raghow R, Stricklin GP, Seyer JM, Kang AH (1986) Post-transcriptional inhibition of collagen and fibronectin synthesis by a synthetic homolog of a portion of the carboxyl terminal propeptide of human type I collagen. J Biol Chem 261:14355–14362PubMedGoogle Scholar
  3. Azzarone B, Macieira-Coelho A (1984) Role of cytoskeletal elements in the retractile activity of human skin fibroblasts. Exp Cell Res 155:299–304PubMedGoogle Scholar
  4. Barrow MV, Simpson CF, Miller EJ (1974) Lathyrism: a review. Q Rev Biol 49:101–128PubMedGoogle Scholar
  5. Bauer EA (1984) Inhibition of collagenase expression in normal and recessive dystrophic epidermolysis bullosa fibroblast cultures by retinoic acid (Abstr 33). Dermatologica 169:234Google Scholar
  6. Bauer EA, Valle KJ (1982) Colchicine induced modulation of collagenase in human skin fibroblast cultures. I. Stimulation of enzyme synthesis in normal cells. J Invest Dermatol 79:398–402PubMedGoogle Scholar
  7. Bauer EA, Cooper TW, Tucker DR, Esterly NB (1980) Phenytoin therapy of recessive dystrophic epidermolysis bullosa: clinical trial and proposed mechanism of action on collagenase. N Engl J Med 303:776–781PubMedGoogle Scholar
  8. Bauer EA, Kronberger A, Valle KJ, Jeffrey JJ, Eisen AZ (1985) Glucocorticoid modulation of collagenase expression in human skin fibroblast cultures. Evidence for pretranslational inhibition. Biochim Biophys Acta 825:227–235PubMedGoogle Scholar
  9. Baum BJ, Moss J, Breul SD, Berg RA, Crystal RG (1980) Effect of cyclic AMP on the intracellular degradation of newly synthesized collagen. J Biol Chem 255:2843–2847PubMedGoogle Scholar
  10. Bell E, Ivarsson B, Merrill C (1979) Production of a tissue like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 76:1274–1278PubMedGoogle Scholar
  11. Beratis NG, Yee M, Labadie GU, Hirschhorn K (1980) Effect of copper on Menkes’ and normal cultured skin fibroblasts. Dev Pharmacol Ther 1:305–317PubMedGoogle Scholar
  12. Bergenholtz A, Hanstrom L (1979) The effect of diphenylhydantoin upon the biosynthesis and degradation of collagen in cat palatal mucosa in organ culture. Biochem Pharmacol 28:2653–2660PubMedGoogle Scholar
  13. Black MM, Shuster S, Bottoms E (1973) Skin collagen and thickness in Cushing’s syndrome. Arch Dermatol Forsch 246:365–368PubMedGoogle Scholar
  14. Blumenkrantz N, Weismann K, Asboe-Hansen G (1979) Lack of dermal changes in uninvolved skin after photochemotherapy of psoriasis: biochemical studies. Acta Derm Venereol (Stockh) 59:149–151Google Scholar
  15. Bohlen P, Baird A, Esch F, Ling N, Gospodarowicz D (1984) Isolation and partial molecular characterization of pituitary fibroblast growth factor. Proc Natl Acad Sci USA 81:5364–5368PubMedGoogle Scholar
  16. Boucek RJ, Speropoulos AJ, Noble NL (1972) Serotonin and ribonucleic acid and collagen metabolism of fibroblasts in vitro. Proc Soc Exp Biol Med 140:599–603PubMedGoogle Scholar
  17. Brinckerhoff CE, Harris ED (1981) Modulation by retinoid acid and corticosteroids of collagenase production by rabbit synovial fibroblasts treated with phorbol myristate acetate or polyethylene glycol. Biochim Biophys Acta 677:424–431PubMedGoogle Scholar
  18. Brinckerhoff CE, Plucinska IM, Sheldon LA, O’Connor GT (1986) Half life of synovial cell collagenase mRNA is modulated by phorbol myristate acetate but not by all-trans-retinoic acid or dexamethasone. Biochemistry 25:6378–6384PubMedGoogle Scholar
  19. Buckley A, Davidson JM, Kamerath CD, Wolt TB, Woodward SC (1985) Sustained release of epidermal growth factor accelerates wound repair. Proc Natl Acad Sci USA 82:7340–7344PubMedGoogle Scholar
  20. Chvapil M (1975) Pharmacology of fibrosis: definitions, limits and perspectives. Life Sci 16:1345–1362PubMedGoogle Scholar
  21. Chvapil M, McCarthy D, Madden JW, Peacock EE (1974) Effect of 1, 10-phenanthroline and desferrioxamine in vivo on prolyl hydroxylase and hydroxylation of collagen in various tissues of rats. Biochem Pharmacol 23:2165–2173PubMedGoogle Scholar
  22. Clark JG, Starcher BC, Uitto J (1980) Bleomycin induced synthesis of type I procollagen by human lung and skin fibroblasts in culture. Biochim Biophys Acta 631:359–370PubMedGoogle Scholar
  23. Cockayne D, Sterling KM, Shull S, Mintz KP, Illeyne S, Cutroneo KR (1986) Glucocorticoids decrease the synthesis of type I procollagen mRNAs. Biochemistry 25:3202–3209PubMedGoogle Scholar
  24. Cohen S (1983) The epidermal growth factor (EGF) Cancer 51:1787–1791PubMedGoogle Scholar
  25. Cohen S, Carpenter G (1975) Human epidermal growth factor: isolation and chemical and biological properties. Proc Natl Acad Sci USA 72:1317–1321PubMedGoogle Scholar
  26. Colige A, Nusgens B, Lapière CM (1987) The effect of EGF on human skin fibroblasts is modulated by the extracellular matrix. Arch Dermatol Res 280:S42–S46Google Scholar
  27. Coulomb B, Dubertret L, Bell E, Touraine R (1984) The contractility of fibroblasts in a collagen lattice is reduced by corticosteroids. J Invest Dermatol 82:341–344PubMedGoogle Scholar
  28. Cruess RL, Hong KC (1975) Effect of cortisone on collagenolytic activity in the rat. Proc Soc Exp Biol Med 148:887–892PubMedGoogle Scholar
  29. Davis WM, Madden JW, Peacock EE (1972) A new approach to the control of esophageal stenosis. Ann Surg 176:469–476PubMedGoogle Scholar
  30. Dayer JM, Krane SM, Russell RGG, Robinson DR (1976) Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc Natl Acad Sci USA 73:945–949PubMedGoogle Scholar
  31. Delbarre F, Godeau P, Thivolet J (1981) Factor XIII treatment for scleroderma. Lancet 2:204PubMedGoogle Scholar
  32. Duksin D, Bornstein P (1977) Impaired conversion of procollagen to collagen by fibroblasts and bone treated with tunicamycin, an inhibitor of protein glycosylation. J Biol Chem 252:955–962PubMedGoogle Scholar
  33. Edward M (1986) Ascorbate induced changes in glycosaminoglycan synthesis and distribution of normal and SV40-transformed fibroblasts. J Cell Sci 85:217–229PubMedGoogle Scholar
  34. Flaherty M, Chojkier M (1986) Selective inhibition of collagen synthesis by the Ca2 + iono-phore A23187 in cultured human fibroblasts. J Biol Chem 261:12060–12065PubMedGoogle Scholar
  35. Folkman J, Haudenschild C (1980) Angiogenesis in vitro. Nature 288:551–556PubMedGoogle Scholar
  36. Franklin TJ, Gregory H, Morris WP (1986) Acceleration of wound healing by recombinant human urogastrone (epidermal growth factor). J Lab Clin Med 108:103–108PubMedGoogle Scholar
  37. Freundlich B, Bomalaski JS, Neilson E, Jimenez SA (1986) Regulation of fibroblasts proliferation and collagen synthesis by cytokines. Immunol Today 7:303–307Google Scholar
  38. Gadek JE, Fulmen JD, Gelfand JA, Franck MM, Petty TL, Crystal RG (1980) Danazolinduced augmentation of serum alpha 1 antitrypsin levels in individuals with marked deficiency of this antiprotease. J Clin Invest 66:82–87PubMedGoogle Scholar
  39. Gospodarowicz D (1975) Purification of a fibroblast growth factor from bovine pituitary. J Biol Chem 250:2515–2520PubMedGoogle Scholar
  40. Gospodarowicz D, Moran JS (1974) Stimulation of division of sparse and confluent 3T3 cell population by a fibroblast growth factor, dexamethasone and insulin. Proc Natl Acad Sci USA 71:4584–4588PubMedGoogle Scholar
  41. Gospodarowicz D, Cheng J, Lui GM, Baird A, Bohlen P (1984) Isolation of brain fibroblast growth factor by heparin Sepharose affinity chromatography: identity with pituitary fibroblast growth factor. Proc Natl Acad Sci USA 81:6963–6967PubMedGoogle Scholar
  42. Goustin AS, Leof EB, Shipley GD, Moses HL (1986) Growth factors and cancer. Cancer Res 46:1015–1029PubMedGoogle Scholar
  43. Halme J, Uitto J, Kahanpaa K, Karhunen P, Lindy S (1970) Protocollagen proline hydroxylase activity in experimental pulmonary fibrosis of rats. J Lab Clin Med 75:535–541PubMedGoogle Scholar
  44. Hamalainen L, Oikarinen J, Kivirikko KI (1985) Synthesis and degradation of type I procollagen mRNAs in cultured human skin fibroblasts and the effect of Cortisol. J Biol Chem 260:720–725PubMedGoogle Scholar
  45. Hansen TM, Andreassen TT, Lorenzen I (1978) Reversibility of the effects of cyclophosphamide on collagen: biochemical studies on skin and granulation tissue and determination of thermal stability of tail tendons of rats. Acta Pharmacol Toxicol (Copenh) 42:103–109Google Scholar
  46. Harris ED, Krane SM (1971) Effects of colchicine on collagenase in cultures of rheumatoid synovium. Arthritis Rheum 14:669–684PubMedGoogle Scholar
  47. Harris ED, Hoffmann GS, McGuire JL, Strosberg JM (1975) Colchicine: effects upon urinary hydroxyproline excretion in patients with scleroderma. Metabolism 24:529–535PubMedGoogle Scholar
  48. Hatamochi A, Fugiwara K, Weki H (1985) Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin. Arch Dermatol Res 277:60–64PubMedGoogle Scholar
  49. Hatamochi A, Paterson B, de Crombrugghe B (1986) Differential binding of a CCAAT DNA binding to the promoters of the mouse alpha 2 (I) and alpha 1 (III) collagen genes. J Biol Chem 261:11310–11314PubMedGoogle Scholar
  50. Herfert J, Wienker TF, Ropers HH (1980) The presence of androgen binding receptors in genital and non genital skin fibroblasts. Hum Genet 53:271–273PubMedGoogle Scholar
  51. Hiramatsu M, Hatakeyama K, Abe I, Minami N (1979) The effect of diphenylhydantoin sodium on acid mucopolysaccharide and collagen contents of cotton pellet granulomas in rats. J Periodontal Res 14:173–177PubMedGoogle Scholar
  52. Hoppe W, Glossi J, Kresse H (1985) Influence of monensin on biosynthesis, processing and secretion of proteodermatan sulfate by skin fibroblasts. Eur J Biochem 152:91–97PubMedGoogle Scholar
  53. Hosokawa M, Ishii M, Inoue K, Yao C, Takeda T (1981) Estrogen induces different responses in dermal and lung fibroblasts: special reference to collagen. Connect Tissue Res 9:115–120PubMedGoogle Scholar
  54. Housley TJ, Rowland FN, Ledger PW, Kaplan J, Tanzer ML (1980) Effects of tunicamycin on the biosynthesis of procollagen by human fibroblasts. J Biol Chem 255:121–128PubMedGoogle Scholar
  55. Huey J, Narayanan AS, Jones K, Page RC (1980) Effect of epidermal growth factor on the synthetic activity of human fibroblasts. Biochim Biophys Acta 632:227–233PubMedGoogle Scholar
  56. Ivanovic V, Weinstein B (1981) Glucocorticoids and benzo[a]pyrene have opposing effects on EGF receptor binding. Nature 293:404–406PubMedGoogle Scholar
  57. Iwatsuki K, Cardinale GJ, Spector S, Udenfriend S (1977) Reduction of blood pressure and vascular collagen in hypertensive rats by beta-aminopropionitrile. Proc Natl Acad Sci USA 74:360–362PubMedGoogle Scholar
  58. Junker P, Helin G, Lorenzen IB (1981) Effect of D-penicillamine on collagen, glycosami-noglycans, DNA and RNA of granulation tissue and connective tissue of skin, bone and aorta in rats. Acta Pharmacol Toxicol (Copenh) 48:300–310Google Scholar
  59. Katoh Y, Kodama K, Ishikawa T (1985) In vivo effects of epidermal and fibroblast growth factors on DNA replication in mouse skin. Exp Cell Res 161:111–116PubMedGoogle Scholar
  60. Keiser HR, Sjoerdsma A (1967) Studies on beta-aminopropionitrile in patients with scleroderma. Clin Pharmacol Ther 8:593–602PubMedGoogle Scholar
  61. Kleinerman J, Ranga V, Rynbrandt D, Sorensen J, Powers JC (1980) The effect of the specific elastase inhibitor, alanyl alanyl prolyl alanine chloromethylketone, on elastase-induced emphysema. Am Rev Respir Dis 121:381–387PubMedGoogle Scholar
  62. Kligman LH, Duo CH, Kligman AM (1984) Topical retinoic acid enhances the repair of ultraviolet damaged dermal connective tissue. Connect Tissue Res 12:139–150PubMedGoogle Scholar
  63. Koob TJ, Jeffrey JJ, Eisen AZ (1974) Regulation of human skin collagenase activity by hydrocortisone and dexamethasone in organ culture. Biochem Biophys Res Commun 61:1083–1088PubMedGoogle Scholar
  64. Krane SM (1982) Collagenases and collagen degradation. J Invest Dermatol 79:83S–85SPubMedGoogle Scholar
  65. Krieg T, Horlein D, Wiestner M, Muller PK (1978) Aminoterminal extension peptides from type I procollagen normalize excessive collagen synthesis of scleroderma fibroblasts. Arch Dermatol Res 263:171–180PubMedGoogle Scholar
  66. Kuivaniemi H, Ala-Kokko L, Kivirikko KI (1986) Secretion of lysyl oxidase by cultured human skin fibroblasts and effects of monensin, nigerian, tunicamycin and colchicine. Biochim Biophys Acta 883:326–334PubMedGoogle Scholar
  67. Kumakiri M, Hashimoto K, Willis I (1977) Biologic changes due to long wave ultraviolet irradiation on human skin: ultrastructural study. J Invest Dermatol 69:392–400PubMedGoogle Scholar
  68. Laato M, Niinikoski J, Lebel L, Gerdin B (1986) Stimulation of wound healing by epidermal growth factor: a dose dependent effect. Ann Surg 203:379–381PubMedGoogle Scholar
  69. Lapière CM (1977) Les médications antiscléreuses. Med Hyg 35:2677–2678Google Scholar
  70. Madden JW, Chvapil M, Carlson EC, Ryan JN (1973) Toxicity and metabolic effects of 3,4-dehydroproline in mice. Toxicol Pharmacol 26:426–437Google Scholar
  71. Manthorpe R, Garbarsch C, Lorenzen I (1980) Long term effect of glucocorticoid on connective tissue of aorta and skin. Morphological and biochemical studies of tissues from rabbits with intact and injured aortas. Acta Endocrinol (Copenh) 95:271–281Google Scholar
  72. Mata JM, Assad R, Peterkosfsky B (1981) An intramembranous reductant which participates in the proline hydroxylation reaction with intracisternal prolylhydroxylase and unhydroxylated procollagen in isolated microsomes from L-929 cells. Arch Biochem Biophys 206:93–104PubMedGoogle Scholar
  73. Maugh T (1981) Angiogenesis inhibitors link many diseases. Science 212:1374–1375PubMedGoogle Scholar
  74. McKusick VA; Neufeld E, Kelley TE (1978) The mucopolysaccharide storage diseases. In: Stanbury IB, Wyngaarden JB, Frederickson DS (eds) The metabolic basis of inherited disease, 4th edn. McGraw-Hill, New YorkGoogle Scholar
  75. McNelis B, Cutroneo KR (1978) A selective decrease of collagen peptide synthesis by dermal polysomes isolated from glucocorticoid treated newborn rats. Mol Pharmacol 14:1167–1175PubMedGoogle Scholar
  76. Morikawa T, Tuderman L, Prockop DJ (1980) Inhibitors of procollagen JV-protease. Synthetic peptides with sequences similar to the cleavage site in the pro-alpha I chain. Biochemistry 19:2646–2650PubMedGoogle Scholar
  77. Mosher DF (1975) Cross-linking of cold insoluble globulin by fibrin stabilizing factor. J Biol Chem 250:6614–6621PubMedGoogle Scholar
  78. Murad S, Grove D, Lindberg KA, Reynolds G, Sivarajah A, Pinnell SR (1981) Regulation of collagen synthesis by ascorbic acid. Proc Natl Acad Sci USA 78:2879–2882PubMedGoogle Scholar
  79. Murray J, Lindberg K, Pinnell S (1977) In vitro inhibition of collagen cross-links by catechol analogs. J Invest Dermatol 68:146–150PubMedGoogle Scholar
  80. Neufeld G, Gospodarowicz D (1985) The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. J Biol Chem 260:13860–13868PubMedGoogle Scholar
  81. Nimni ME (1977) Mechanism of inhibition of collagen cross-linking by penicillamine. Proc R Soc Med 70:65–72PubMedGoogle Scholar
  82. Nusgens B, Gielen J, Lapière CM (1978) Inhibition of collagen synthesis by the aminoterminal extension of procollagen. J Invest Dermatol 70:230Google Scholar
  83. Ohuchi K, Tsurufuji S (1970) Degradation and turnover of collagen in the mouse skin and the effect of whole body X-irradiation. Biochim Biophys Acta 208:475–481PubMedGoogle Scholar
  84. Ohuchi K, Chang LF, Tabachnick J (1979) Radiation fibrosis of guinea pig skin after beta irradiation and an attempt at its suppression with proline analogs. Radiat Res 79:273–288PubMedGoogle Scholar
  85. Oikarinen A, Salo T (1986) Effects of retinoids on type IV collagenolytic activity in melanoma cells. Acta Derm Venereol (Stockh) 66:346–348Google Scholar
  86. Oikarinen H, Oikarinen AI, Tan EML, Abergel RP, Meeker CA, Chu ML, Prockop DJ, Uitto J (1985) Modulation of procollagen gene expression by retinoids. Inhibition of collagen production by retinoic acid accompanied by reduced type I procollagen messenger ribonucleic acid levels in human skin fibroblast cultures. J Clin Invest 75:1545–1553PubMedGoogle Scholar
  87. Oikarinen J (1977) Effect of Cortisol acetate on collagen biosynthesis and on the activities of prolyl hydroxylase, lysyl hydroxylase, collagen galactosyltransferase and collagen glucosyltransferase in chick embryo tendon cells. Biochem J 164:533–539PubMedGoogle Scholar
  88. Oikarinen J, Hannuksela M (1980) Effects of hydrocortisone-17-butyrate, hydrocortisone and clobetasol-17-propionate on prolyl hydroxylase activity in human skin. Arch Dermatol Res 267:79–82PubMedGoogle Scholar
  89. Oikarinen J, Ryhanen L (1981) Cortisol decreases the concentration of translatable type I procollagen mRNA species in the developing chick embryo cal varia. Biochem J 198:519–524PubMedGoogle Scholar
  90. Oikarinen J, Pihlajaniemi T, Hamalainen L, Kivirikko KI (1983) Cortisol decreases the cellular concentration of translatable procollagen mRNA species in cultured human skin fibroblasts. Biochim Biophys Acta 741:297–302PubMedGoogle Scholar
  91. Oliver N (1986) Molecular mechanism of glucocorticoid enhanced fibronectin gene expression. Coll Relat Res 6:441Google Scholar
  92. Paglia LM, Wilczek J, Diaz de Leon L, Martin GR, Horlein D, Muller P (1979) Inhibition of procollagen cell free synthesis by aminoterminal extension peptides. Biochemistry 18:5030–5034PubMedGoogle Scholar
  93. Paglia LM, Wiestner M, Duchene M, Ouellette LA, Horlein D, Martin GR, Muller PK (1981) Effects of procollagen peptides on the translation of type II collagen messenger ribonucleic acid and on collagen biosynthesis in chondrocytes. Biochemistry 20:3523–3527PubMedGoogle Scholar
  94. Paye M, Lapière CM (1986) The lack of attachment of transformed embryonic lung epithelial cells to collagen I is corrected by fibronectin and FXIII. J Cell Sci 86:95–107PubMedGoogle Scholar
  95. Paye M, Etievant C, Michiels F, Pierard D, Nusgens B, Lapière CM (1986) Characterization of a spontaneously transformed pulmonary embryonic rat (PER) epithelial cell line. J Cell Sci 86:83–93PubMedGoogle Scholar
  96. Pierard GE, Ackerman A (1979) Histopathology of remodelling induced by PUVA within superficial dermis. Br J Dermatol 100:251–256PubMedGoogle Scholar
  97. Pierard GE, de la Brassinne M, Lapière CM (1977) Effects of long term photochemo-therapy on the dermis. J Invest Dermatol 68:249–250Google Scholar
  98. Pinnell SR, Martin GR (1968) The cross-linking of collagen and elastin: enzymatic conversion of lysine in peptide linkage to alpha-aminoadipic-8-semialdehyde (allysine) by an extract from bone. Proc Natl Acad Sci USA 61:708–714PubMedGoogle Scholar
  99. Pohl J, Christophers E (1979) Photoinactivation of skin fibroblasts by fractionated treatment with 8-methoxypsoralen and UVA. J Invest Dermatol 73:176–179PubMedGoogle Scholar
  100. Ponec M (1984) Effects of glucocorticoids on cultured skin fibroblasts and keratinocytes. Int J Dermatol 23:11–24PubMedGoogle Scholar
  101. Ponec M, Kempenaar JA, van der Meulen-van Harskamp GA, Bachra BN (1979) Effects of glucocorticosteroids on cultured human skin fibroblasts. IV — Specific decrease in the synthesis of collagen but no effect on its hydroxylation. Biochim Pharmacol 28:2777–2783Google Scholar
  102. Poole AR (1975) Immunocytochemical studies of the secretion of a proteolytic enzyme ca-thepsin D, in relation to cartilage breakdown. In: Burleigh PMC, Poole AR (eds) Dynamics of connective tissue macromolecules. North-Holland, Amsterdam, pp 357–406Google Scholar
  103. Prockop DJ, Kivirikko KI, Tuderman L, Guzman NA (1979) The biosynthesis of collagen and its disorders. N Engl J Med 301:13–23PubMedGoogle Scholar
  104. Raghow R, Lurie S, Seyer JM, Kang AH (1985) Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin and fibronectin in hamster lungs undergoing bleomycin induced interstitial pulmonary fibrosis. J Clin Invest 76:1733–1739PubMedGoogle Scholar
  105. Rakll LB, Scott J, Bell GI, Crawford RJ, Penschow JD, Niall HD, Coghlan J (1985) Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature 313:228–231Google Scholar
  106. Roberts AB, Sporn MB (1986) Transforming growth factors. Cancer Surv 4:683–694Google Scholar
  107. Robinson DR, Smith H, Levine L (1973) Prostaglandin (PG) synthesis by human synovial cultures and its stimulation by colchicine. Arthritis Rheum 16:129–136Google Scholar
  108. Rojkind M, Uribe M, Kersenobich D (1973) Colchicine and the treatment of liver cirrhosis. Lancet 7793:38–39Google Scholar
  109. Rokowski RJ, Sheehy J, Cutroneo KR (1981) Glucocorticoid mediated selective reduction of functioning collagen messenger ribonucleic acid. Arch Biochem Biophys 210:74–81PubMedGoogle Scholar
  110. Rosenbloomj, Feldman G, Freundlich B, Jimenez SA (1986) Inhibition of excessive scleroderma fibroblast collagen production by recombinant gamma interferon. Association with a coordinate decrease in type I and type III procollagen messenger RNA levels. Arthritis Rheum 29:851–856PubMedGoogle Scholar
  111. Ross R (1985) Platelets, platelet-derived growth factor, growth control, and their interactions with the vascular wall. J Cardiovasc Pharmacol 7:S186–S190PubMedGoogle Scholar
  112. Royce PM, Camakaris J, Danks DM (1980) Reduced lysyl oxidase activity in skin fibroblasts from patients with Menkes’ syndrome. Connect Tissue Res 7:205–211Google Scholar
  113. Saarni H (1978) Cortisol effects on the glycosaminoglycan synthesis and molecular weight distribution in vitro. Biochem Pharmacol 27:1029–1032PubMedGoogle Scholar
  114. Sanada H, Shikata J, Hamamoto H, Ueba Y, Yamamuro T, Takeda T (1978) Changes in collagen cross-linking and lysyl oxidase by estrogen. Biochim Biophys Acta 541:408–414PubMedGoogle Scholar
  115. Sandberg LB, Zeikus RD, Coltrain IM (1971) Tropoelastin purification from copper deficient swine: a simplified method. Biochim Biophys Acta 236:542PubMedGoogle Scholar
  116. Sandberg LB; Soskel NT, Leslie JG (1981) Elastin structure, biosynthesis and relation to disease states. N Engl J Med 304:566–579PubMedGoogle Scholar
  117. Schein J, Harsch M, Cywinski A, Rosenbloom J (1980) Effect of the arginine analog, ca-navanin, on the synthesis and secretion of procollagen. Arch Biochem Biophys 203:572–579PubMedGoogle Scholar
  118. Schmidt A, Setoyama C, de Crombrugghe B (1985) Regulation of a collagen gene promoter by the product of viral mos oncogene. Nature 314:286–289PubMedGoogle Scholar
  119. Setoyama C, Hatamochi A, Peterkofsky B, Prather W, de Crombrugghe B (1986) V-fos stimulates expression of the alpha 1 (III) collagen gene in NIH 3T3 cells. Biochem Biophys Res Commun 136:1042–1048PubMedGoogle Scholar
  120. Shapiro SS, Mott DJ (1981) Modulation of glycosaminoglycan biosynthesis by retinoids. Modulation of cellular interactions by vitamin A and derivatives (retinoids). Ann NY Acad Sci 359:306–321PubMedGoogle Scholar
  121. Shaw SN, Amos H (1973) Insulin stimulation of glucose entry in chick fibroblast and Hela cells. Biochem Biophys Res Commun 5:357–365Google Scholar
  122. Shull S, Cutroneo KR (1986) Glucocorticoids change the ratio of type III to type I procollagen extracellularly. Coll Relat Res 6:295–300PubMedGoogle Scholar
  123. Shuster S, Raffle EJ, Bottoms E (1967) Skin collagen in rheumatoid arthritis and the effects of corticosteroids. Lancet 1:525–527Google Scholar
  124. Shuster S, Black MM, MacVitie E (1975) The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol 93:639–643PubMedGoogle Scholar
  125. Siegel RC (1977) Collagen cross-linking. Effect of D-penicillamine on cross-linking in vitro. J Biol Chem 252:254–259PubMedGoogle Scholar
  126. Siegel RC (1979) Lysyl oxidase. Int Rev Connect Tissue Res 8:73–118PubMedGoogle Scholar
  127. Soria J, Soria C, Boulard C (1975) Fibrin stabilizing factor (FXIII) and collagen polymerization. Experientia 31:1355–1357PubMedGoogle Scholar
  128. Steinmann BU, Abe S, Martin GR (1982) Modulation of type I and type III collagen production in normal and mutant human skin fibroblasts by cell density, prostaglandin E2 and epidermal growth factor. Coll Relat Res 2:185–195PubMedGoogle Scholar
  129. Sykes BC, Partridge SM (1974) Salt soluble elastin from lathyritic chicks. Biochem J 141:567–572PubMedGoogle Scholar
  130. Uchida N, Smilowitz H, Tanzer ML (1979) Monovalent ionophores inhibit secretion of procollagen and fibronectin from cultured human fibroblasts. Proc Natl Acad Sci USA 76:1868–1872PubMedGoogle Scholar
  131. Uitto J (1969) Effect of D-penicillamine on collagen biosynthesis in organ culture. Biochim Biophys Acta 194:498–503PubMedGoogle Scholar
  132. Uzuka M, Nakajima K, Ohta S, Mori Y (1981) Induction of hyaluronic acid synthetase by estrogen in the mouse skin. Biochim Biophys Acta 673:387–393PubMedGoogle Scholar
  133. Vaatainen N, Oikarinen A, Kuutti-Savolainen ER (1980) The effects of long-term local PUVA treatment on collagen metabolism in human skin. Arch Dermatol Res 269:99–104PubMedGoogle Scholar
  134. Van Caneghem P, Lapière CM (1975) Influence des rayons X sur la vitesse de dépolymérisation des fibres de collagène lathyrique reconstituées in vitro. C R Soc Biol (Paris) 16:242–245Google Scholar
  135. Van Story-Lewis PE, Tenenbaum HC (1986) Glucocorticoid inhibition of fibroblast contraction of collagen gels. Biochem Pharmacol 35:1283–1286PubMedGoogle Scholar
  136. Verbruggen LA, Abe S (1982) Glucocorticoids alter the ratio of type III type I collagen synthesis by mouse dermal fibroblasts. Biochem Pharmacol 31:1711–1715PubMedGoogle Scholar
  137. Villee DB, Powers ML (1977) Effect of glucose and insulin on collagen secretion by human skin fibroblasts in vitro. Nature 268:156–157PubMedGoogle Scholar
  138. Wahl LM (1977) Hormonal regulation of macrophage collagenase activity. Biochem Bio-phys Res Commun 74:838–845Google Scholar
  139. Wahl LM, Olsen CE, Sandberg AL, Mergenhagen SE (1977) Prostaglandin regulation of macrophage collagenase production. Proc Natl Acad Sci USA 74:4955–4958PubMedGoogle Scholar
  140. Walthall BJ, Ham RG (1981) Multiplication of human diploid fibroblasts in a synthetic medium supplemented with EGF, insulin and dexamethasone. Exp Cell Res 134:303–311PubMedGoogle Scholar
  141. Wauters P, Eeckhout Y, Vaes G (1986) Oxidation products are responsible for the resistance to the action of collagenase conferred on collagen by (+)-catechin. Biochem Pharmacol 35:2971–2973PubMedGoogle Scholar
  142. Wells BR, Birkedal-Hansen H (1985) Retinoic acid stimulates degradation of interstitial collagen fibrils by rat mucosal keratinocytes in vitro. J Dent Res 64:1186–1190PubMedGoogle Scholar
  143. Werb Z (1978) Biochemical actions of glucocorticoids on macrophages in cultures. Specific inhibition of elastase, collagenase and plasminogen activator secretion and effects on other metabolic functions. J Exp Med 147:1695–1712PubMedGoogle Scholar
  144. Wie H, Beck EI (1981) Synthesis and solubility of collagen in rats during recovery after high dose cyclophosphamide administration. Acta Pharmacol Toxicol (Copenh) 48:294–299Google Scholar
  145. Wiestner P, Krieg T, Horlein D, Glanville RW, Fietzek P, Muller PK (1979) Inhibiting effect of procollagen peptides on collagen biosynthesis in fibroblast cultures. J Biol Chem 254:7016–7023PubMedGoogle Scholar
  146. Woessner JF (1969) Inhibition by oestrogen of collagen breakdown in the involuting rat uterus. Biochem J 112:637–645PubMedGoogle Scholar
  147. Wolff K, Gschnait F, Honigsmann H, Konrad K, Stingl G, Wolff-Schreiner E, Fritsch P (1976) Oralphotochemotherapy: results, follow-up and pathology. In: Farber EM, Cox AJ (eds) Psoriasis. Yorke, New York, p 300Google Scholar
  148. Wu CH, Donovan CB, Wu GY (1986) Evidence for pretranslational regulation of collagen synthesis by procollagen propeptides. J Biol Chem 261:10482–10484PubMedGoogle Scholar
  149. Yoshizato K, Nishikawa A, Taira T, Koganei Y, Yamamoto N, Kishi J, Hayakawa T (1986) A reconstituted skin: dermal-epidermal interactions in collagenolysis and cell morphology. Biomed Res 7:219–231Google Scholar
  150. Zimmermann B, Tsambaos D (1985) Retinoids inhibit the differentiation of embryonic mouse mesenchymal cells in vitro. Arch Dermatol Res 277:98–104PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • B. Nusgens
  • C. M. Lapière

There are no affiliations available

Personalised recommendations